10-Year vasculitis study aims to predict relapses and improve care
NCT ID NCT07586137
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 300 people with suspected or confirmed systemic vasculitis for up to 10 years. Researchers will collect medical data, images, and blood samples to identify factors that predict relapses, complications, and death. The goal is to better understand the disease and help design future treatments, but no new therapy is being tested.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2022
- Expected to finish
-
Jun 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients with a diagnosis of vasculitis
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Willing and able to give informed consent * clinical suspicion or a confirmed diagnosis of Systemic Vasculitis Exclusion Criteria: * Inability to give informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Vasculitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Fondazione IRCCS Policlinico San Matteo, SC Reumatologia
RECRUITINGPavia, Pavia, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cancer immunotherapy can attack the heart: massive data hunt seeks who is most vulnerable
- Can better sleep ease pain in teens with rheumatic disease?
- Could an arthritis drug shrink dangerous brain aneurysms?
- New study aims to spot eye damage early in rare vasculitis patients
- Massive study reveals hidden dangers of common steroid treatments
- Scientists track prednisolone levels to improve dosing for inflammatory conditions